Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FATE | AMGN | GILD | VRTX | REGN |
| Company | Fate Therapeutics | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 4.14 | 273.45 | 67.47 | 402.44 | 911.09 |
| High | 4.15 | 274.35 | 67.90 | 403.88 | 915.00 |
| Low | 3.90 | 267.24 | 65.32 | 393.00 | 876.75 |
| Last | 3.93 | 267.81 | 65.61 | 396.40 | 888.67 |
| Change | -0.37 | -5.20 | -1.47 | -4.36 | -17.87 |
| % Change | -8.60% | -1.90% | -2.19% | -1.09% | -1.97% |
| Volume | 956,391 | 524,018 | 4,000,991 | 262,798 | 222,114 |
| 20-Day Average Volume | 2,123,488 | 2,084,862 | 6,282,957 | 936,778 | 435,369 |
| Previous Close | 4.30 | 273.01 | 67.08 | 400.76 | 906.54 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.86 | 270.63 | 68.70 | 402.15 | 922.34 |
| 20-Day Raw Stochastic | 1.47% | 26.21% | 3.86% | 11.60% | 11.36% |
| 20-Day Relative Strength | 27.84% | 43.63% | 29.21% | 40.69% | 34.17% |
| Weighted Alpha | -57.89 | +8.34 | -23.11 | +13.61 | +10.55 |
| Today's Opinion | 8% Sell | 72% Sell | 100% Sell | 8% Buy | 8% Sell |
| Previous Opinion | 8% Buy | 40% Sell | 100% Sell | 8% Buy | 24% Buy |
| Last Month's Opinion | 80% Buy | 24% Buy | 88% Sell | 56% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -21.33% since 04/18/24 | +1.99% since 04/18/24 | -0.77% since 04/18/24 | +0.27% since 04/18/24 | -0.73% since 04/18/24 |
| Low | 3.91 on 04/25/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 | 391.25 on 04/19/24 | 876.75 on 04/25/24 |
| High | 5.11 on 04/19/24 | 274.86 on 04/24/24 | 67.78 on 04/25/24 | 406.86 on 04/23/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | -42.29% since 03/25/24 | -4.57% since 03/25/24 | -9.55% since 03/25/24 | -5.17% since 03/25/24 | -7.66% since 03/25/24 |
| Low | 3.91 on 04/25/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 | 391.01 on 04/18/24 | 876.75 on 04/25/24 |
| High | 7.65 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | -13.05% since 01/25/24 | -13.62% since 01/25/24 | -18.17% since 01/25/24 | -8.24% since 01/25/24 | -6.48% since 01/25/24 |
| Low | 3.91 on 04/25/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 | 391.01 on 04/18/24 | 876.75 on 04/25/24 |
| High | 8.83 on 03/07/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +120.28% since 10/25/23 | -1.53% since 10/25/23 | -16.25% since 10/25/23 | +8.68% since 10/25/23 | +11.34% since 10/25/23 |
| Low | 1.63 on 10/30/23 | 249.70 on 10/31/23 | 65.32 on 04/25/24 | 341.90 on 11/16/23 | 769.19 on 10/27/23 |
| High | 8.83 on 03/07/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 489,413 | 146,436,016 | 83,519,768 | 103,580,040 | 99,503,640 |
| Shares Outstanding, K | 113,817 | 536,376 | 1,245,077 | 258,459 | 109,762 |
| Annual Sales | 63,530,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | -160,930,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 1,680,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 3,434,300,000 |
| Last Quarter Net Income | -44,120,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 1,159,600,000 |
| 60-Month Beta | 1.66 | 0.58 | 0.19 | 0.35 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.45 on 02/26/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/01/24 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.67 | 9.97 | 30.13 | 24.14 |